Clinical Trials Directory

Trials / Completed

CompletedNCT06847230

How Does DT1 Sphere Perform in Current and Successful Acuvue MAX Wearers?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Southern College of Optometry · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The goal of this prospective study is to to understand if satisfied MAX Contact lens (CL)wearers can be successfully refit into Dailies total 1 (DT1) CL in healthy MAX CL wearers between the ages of 18-40. The main question is to determine the number of participants who can successfully be re-fit into DT1 CL, by utilizing a cldeq-8 questionnaire as well as an investigator developed questionnaire to gauge comfort and satisfaction.

Conditions

Interventions

TypeNameDescription
DEVICEDailies total 1 contact lensessuccessful refit into dt1 will be determined

Timeline

Start date
2024-07-15
Primary completion
2024-11-01
Completion
2024-11-30
First posted
2025-02-26
Last updated
2025-08-12

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06847230. Inclusion in this directory is not an endorsement.

How Does DT1 Sphere Perform in Current and Successful Acuvue MAX Wearers? (NCT06847230) · Clinical Trials Directory